The nation of Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (£272m) spanning five years over Washington's insistence on sensitive biological samples.
The decision became public following a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official representative later explained that the US was demanding access to genetic material for scientific study and commercial purposes but was not willing to share the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged further negotiations to secure a deal agreeable to all parties so the country's vital HIV treatment initiative can be sustained.
Broader Background
This development follows a similar case in Kenya, where a high court halted a related deal with the US following concerns were raised about the security of citizens' health data.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had managed assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.
Based on statements, Sixteen nations in Africa have to date agreed to these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment via US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to surrender its biological resources and data indefinitely, without any equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," his statement read.
"Effectively, our nation would supply the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our population should a new health crisis emerge."
National Interest and Global Health
He also noted that the US's withdrawal from the global health body and its push of bilateral health agreements were upending systems previously set up via the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to continued dialogue with our American counterparts on how subsequent collaboration could be arranged in a manner that respects the sovereignty and dignity of both nations."
Medical Community Reaction
A leading public health body stated it recognised the official position, but recommended that talks must proceed since a large portion of the country's Aids initiatives relied on foreign aid.
"Where technical issues exist, such as those relating to data governance or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it said.
This impasse highlights the complex challenges between receiving vital international aid and protecting a country's data in an ever more data-driven world.